Y
Yubo International Biotech Ltd
OTC:YBGJ
Yubo International Biotech Ltd
OTC:YBGJ
Price:
0.01
USD
Market Closed
Market Cap:
$1.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Y
|
Yubo International Biotech Ltd
OTC:YBGJ
|
CN |
|
Constellation Brands Inc
NYSE:STZ
|
US |
|
Aarti Drugs Ltd
NSE:AARTIDRUGS
|
IN |
|
A
|
Amplifon SpA
LSE:0N61
|
IT |
Balance Sheet
Balance Sheet Decomposition
Yubo International Biotech Ltd
Yubo International Biotech Ltd
Balance Sheet Decomposition is not available for
Yubo International Biotech Ltd
Yubo International Biotech Ltd
Balance Sheet
Yubo International Biotech Ltd
Yubo International Biotech Ltd
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
1
|
1
|
|
| PP&E Net |
0
|
3
|
1
|
1
|
|
| PP&E Gross |
0
|
3
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
5
N/A
|
2
-49%
|
2
-29%
|
|
| Liabilities | |||||
| Accounts Payable |
0
|
0
|
1
|
1
|
|
| Accrued Liabilities |
0
|
1
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
2
|
2
|
2
|
|
| Total Current Liabilities |
0
|
3
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
2
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
5
+47 100%
|
3
-38%
|
4
+20%
|
|
| Equity | |||||
| Common Stock |
0
|
0
|
0
|
0
|
|
| Retained Earnings |
29
|
2
|
4
|
5
|
|
| Additional Paid In Capital |
29
|
2
|
3
|
3
|
|
| Other Equity |
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
-1 200%
|
1
-335%
|
2
-226%
|
|
| Total Liabilities & Equity |
0
N/A
|
5
N/A
|
2
-49%
|
2
-29%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
118
|
118
|
120
|
120
|
|
Switch to:
Switch to:
See Also
Discover More
